SEC Form 4 · accession 0001127602-19-008805

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 26, 2019

Accepted (ET)

Feb 28, 2019 · 9:49 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 26, 2019	S	10	$139.825	D	297,277	D
Common Stock	Feb 26, 2019	S	40	$139.83	D	297,237	D
Common Stock	Feb 26, 2019	S	800	$139.85	D	296,437	D
Common Stock	Feb 26, 2019	S	30	$139.86	D	296,407	D
Common Stock	Feb 26, 2019	S	1	$139.87	D	296,406	D
Common Stock	Feb 26, 2019	S	200	$139.88	D	296,206	D
Common Stock	Feb 26, 2019	S	47	$139.885	D	296,159	D
Common Stock	Feb 26, 2019	S	43	$139.90	D	296,116	D
Common Stock	Feb 26, 2019	S	30	$139.91	D	296,086	D
Common Stock	Feb 26, 2019	S	10	$139.915	D	296,076	D
Common Stock	Feb 26, 2019	S	200	$139.92	D	295,876	D
Common Stock	Feb 26, 2019	S	100	$139.925	D	295,776	D
Common Stock	Feb 26, 2019	S	400	$139.93	D	295,376	D
Common Stock	Feb 26, 2019	S	30	$139.935	D	295,346	D
Common Stock	Feb 26, 2019	S	10	$139.965	D	295,336	D
Common Stock	Feb 26, 2019	S	500	$139.98	D	294,836	D
Common Stock	Feb 26, 2019	S	130	$139.985	D	294,706	D
Common Stock	Feb 26, 2019	S	30	$139.99	D	294,676	D
Common Stock	Feb 26, 2019	S	30	$139.995	D	294,646	D
Common Stock	Feb 26, 2019	S	97	$140.00	D	294,549	D
Common Stock	Feb 26, 2019	S	1	$140.015	D	294,548	D
Common Stock	Feb 26, 2019	S	630	$140.03	D	293,918	D
Common Stock	Feb 26, 2019	S	130	$140.04	D	293,788	D

No Table II lines on this filing.